Welcome to Trends-in-Medicine, offering independent, cutting-edge articles and information on drugs and devices in development. Our subscribers have access to news and analysis on the latest data, regulatory issues, and trends of interest to the healthcare community.
Weekly Preview for 3/11-17
Here is the medical news to watch for March 11-17, 2024
2024 Medical Calendar - 2nd Half
2024 Medical Calendar - 2nd Half
San Antonio Breast Cancer Symposium: Liquid biopsies for breast cancer
Detecting minimal residual disease (MRD) in a breast cancer patient early sounds like a great idea. Here we look at the latest data on ctDNA testing -- the tests, physician opinions, and patient reactions.
Alzheimer's Update
The data on Eisai and Biogen’s Leqembi (lecanemab) was the highlight of the Clinical Trials on Alzheimer's Disease (CTAD) meeting in Boston. Here we dive into the data.
2024 Medical Calendar - First Half
2024 Medical Calendar - First Half
Retina Update
Three new drugs for geographic atrophy had mixed news at ASRS: (10 A safety issue reported with Apellis Pharmaceuticals’ Syfovre (pegcetacoplan), a complement C3 inhibitor, (2) Efficacy questions about Astellas/Iveric Bio’s Izervay (avacincaptad pegol), a complement C5 inhibitor, and (3) an efficacy miss for Annexon Biosciences’ ANX-007, A complement C1q inhibitor. And there was positive data on sevral other drugs.
AI Perspectives
Where is artificial intelligence going in healthcare? Here is a Perpective from one of our technology-savvy reporters
Medical Calendar
Medical Calendar